We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 21-40 of 10,000 results
  1. Intervention components in the self-management of Parkinson’s: a mixed-methods synthesis of qualitative and quantitative evidence

    Introduction

    Self-management interventions consist of multiple components to support people in the management of medical, emotional, and behavioural...

    Megan Armstrong, Kate Walters, ... Anette Schrag in BMC Health Services Research
    Article Open access 17 January 2024
  2. Apolipoprotein D concentration in Parkinson’s disease patients

    Background

    Parkinson’s disease (PD) is distinguished recently by an increase in inflammation and oxidative stress. Apolipoprotein D (Apo D) is a...

    Hala A. Shaheen, Sayed Sobhy, ... Mohammed Gomaa in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 07 November 2023
  3. Suicide, Moral Injury, Parkinson’s Disease, Diabetes and Dialysis

    This issue of JORH presents the first of a two-part series specifically exploring suicide. Research relating to moral injury is also included—a topic...

    Lindsay B. Carey, Terrence Hill, ... Piret Paal in Journal of Religion and Health
    Article 10 November 2023
  4. Economic burden of Parkinson’s disease and research trends: a bibliometric analysis

    Background

    Parkinson’s disease (PD) is a neurodegenerative disorder associated with a range of motor and non-motor symptom leading to progressive...

    Maura Cunha, Helena Almeida, ... Lara N. Ferreira in Journal of Public Health
    Article Open access 15 June 2024
  5. Prevalence of hallucinations in Parkinson’s patients: meta-analysis of International studies

    Background

    Parkinson’s disease (PD) is one of the common causes of disability in the elderly. This study aims to estimate the prevalence of...

    Somayye Nadi Ravandi, Ebrahim Kouchaki, Fatemeh Sadat Asgarian in Neurological Sciences
    Article 04 May 2023
  6. Nurses, Clergy, Chaplains, Parkinson’s Disease, Workplace Religiosity, Women’s Health and Family Issues

    This issue of JORH explores a broad range of topics looking at the professions of nursing, clergy and chaplains. This issue also concludes the series...

    Lindsay B. Carey, Jeffery Cohen, ... Piret Paal in Journal of Religion and Health
    Article 13 April 2024
  7. Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future

    For a special issue, we review studies on the pathogenesis of nigral cell death and the treatment of sporadic Parkinson’s disease (sPD) over the past...

    Hideki Mochizuki in Journal of Neural Transmission
    Article Open access 12 June 2024
  8. The Relationship Between Religious Coping, Spirituality, and Disease Self-Management Among Parkinson’s Patients in Turkey

    Religion and spirituality can be important motivational tools in the management of Parkinson’s disease. This study was conducted to determine the...

    Özlem Karatana, Baykal Yıldız in Journal of Religion and Health
    Article 20 November 2023
  9. Seborrheic Dermatitis and Parkinson’s Disease

    Purpose of Review

    The present review aims to analyze the most recent publications and theories associated with the increase of seborrheic dermatitis...

    Fabiola Lumbán-Ramírez, Paola Lumbán-Ramírez, ... Alexandro Bonifaz in Current Fungal Infection Reports
    Article 22 March 2024
  10. Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson’s disease

    Background

    Cognitive impairment is a common non-motor symptom of Parkinson’s disease (PD). The apolipoprotein E (APOE) ε4 genotype increases the risk...

    Shi-Guo Zhu, Zhu-Ling Chen, ... Jian-Yong Wang in European Journal of Medical Research
    Article Open access 16 June 2024
  11. Customized treatment for Parkinson’s disease: extending lifespan and improving symptoms

    Background

    Parkinson's disease (PD) is the second most prevalent neurodegenerative ailment affecting aged people. Several motor and non-motor symptoms...

    Article Open access 12 June 2024
  12. Baseline prevalence and longitudinal assessment of autonomic dysfunction in early Parkinson’s disease

    Autonomic dysfunction (AutD) is common and debilitating in Parkinson’s disease (PD). Predictors of AutD are unclear, and data are limited on the...

    Lanqing Yang, Huan Gao, Min Ye in Journal of Neural Transmission
    Article 04 November 2023
  13. Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer’s and Parkinson’s Diseases

    Purpose of Review

    The gut microbiota plays a crucial role in the pathogenesis of neuroinflammation and Alzheimer’s and Parkinson’s diseases. One of...

    Şerife Ayten, Saniye Bilici in Current Nutrition Reports
    Article Open access 23 April 2024
  14. The Impact of Polypharmacy on Management of Lower Urinary Tract Symptoms in Parkinson’s Disease

    Lower urinary tract (LUT) symptoms are a common presentation of autonomic dysfunction in Parkinson’s disease (PD). Symptoms significantly impact...

    Udit Saraf, Amit Batla, ... Jalesh N. Panicker in Drugs & Aging
    Article 31 August 2023
  15. Meaning in Life in Late-Stage Parkinson’s Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries

    The Care of Late-Stage Parkinsonism (CLaSP) study is a longitudinal, multicentre, prospective cohort study to assess the needs and provision of care...

    Sarah K. Bublitz, Cornelia Brandstötter, ... Stefan Lorenzl in Journal of Religion and Health
    Article Open access 05 December 2023
  16. Impacts of gait freeze on quality of life in Parkinson’s disease, from the perspectives of patients and their carers

    Background

    The World Health Organisation (WHO) reports that morbidity and mortality due to Parkinson’s disease (PD) are increasing faster than for...

    Padraig Cronin, Lucy M. Collins, Aideen M. Sullivan in Irish Journal of Medical Science (1971 -)
    Article Open access 19 April 2024
  17. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease

    Introduction

    Ethnicity differences are an important determinant in the clinical manifestation of Parkinson’s disease (PD), but they are not yet widely...

    Carlo Cattaneo, Jaime Kulisevsky in Advances in Therapy
    Article Open access 09 December 2023
  18. Research progress in the early diagnosis of Parkinson’s disease

    Parkinson’s disease is the second major neurodegenerative disease with increasing incidence and population in the world year by year. The...

    LinLin Xie, LuDong Hu in Neurological Sciences
    Article 11 August 2022
  19. Gender differences in non-motor fluctuations in Parkinson’s disease

    Non-motor symptoms (NMS) and Non-motor fluctuations (NMF) in Parkinson’s Disease (PD) are common, involving several domains and affecting quality of...

    Giulia Donzuso, Calogero Edoardo Cicero, ... Alessandra Nicoletti in Journal of Neural Transmission
    Article Open access 01 August 2023
  20. The lived experience of stigma and parkinson’s disease in Kenya: a public health challenge

    Background

    As a disease characterised by non-motor and very visible motor symptoms, Parkinson’s disease has been associated with multiple forms of...

    Natasha Fothergill-Misbah in BMC Public Health
    Article Open access 20 February 2023
Did you find what you were looking for? Share feedback.